通过电融合形成杂交瘤来稳定人爱泼斯坦-巴尔病毒激活的B淋巴细胞的抗体分泌。 - Suppr

Suppr

超能文献

Stabilizing antibody secretion of human Epstein Barr virus-activated B-lymphocytes with hybridoma formation by electrofusion.

作者信息

Perkins S, Foung S K

机构信息

Department of Pathology, Stanford University School of Medicine, CA, USA.

出版信息

Methods Mol Biol. 1995;48:295-307. doi: 10.1385/0-89603-304-X:295.

DOI:10.1385/0-89603-304-X:295

PMID:8528401

Abstract

摘要

相似文献

Stabilizing antibody secretion of human Epstein Barr virus-activated B-lymphocytes with hybridoma formation by electrofusion.

Methods Mol Biol. 1995;48:295-307. doi: 10.1385/0-89603-304-X:295.

Human T cell hybridomas specific for Epstein Barr virus-infected B lymphocytes.

J Immunol. 1983 Jan;130(1):169-72.

Parameters to enhance human hybridoma formation with hypoosmolar electrofusion.

Hum Antibodies Hybridomas. 1991 Jul;2(3):155-9.

Generation of human monoclonal antibodies by fusion of EBV-activated B cells to a human-mouse hybridoma.

Methods Enzymol. 1986;121:168-74. doi: 10.1016/0076-6879(86)21015-0.

Monoclonal antibody to the Epstein-Barr virus receptor induces human B lymphocyte activation and differentiation.

Trans Assoc Am Physicians. 1985;98:290-300.

Incorporation of T cell counterparts in the fusion partners for generation of human monoclonal antibodies from Staphylococcus aureus stimulated B lymphocytes.

Hum Antibodies. 1997;8(1):26-32.

Human-human B cell hybridomas from in vitro stimulated lymphocytes of patients with common variable immunodeficiency.

J Immunol. 1983 Nov;131(5):2273-8.

A human hybrid hybridoma.

J Immunol. 1987 Nov 15;139(10):3402-5.

Development of specific human mab's by a small scale electrofusion technique: the influence of some physical and chemical factors on hybridoma yield of human peripheral blood lymphocytes XCB-F7 fusions.

Allerg Immunol (Leipz). 1989;35(2):123-32.

SPAM-8, a mouse-human heteromyeloma fusion partner in the production of human monoclonal antibodies. Establishment of a human monoclonal antibody against cytomegalovirus.

Hum Antibodies Hybridomas. 1991 Jan;2(1):26-32.

引用本文的文献

Isolation of HCV Neutralizing Antibodies by Yeast Display.

Methods Mol Biol. 2019;1911:395-419. doi: 10.1007/978-1-4939-8976-8_27.

Preclinical evaluation of two neutralizing human monoclonal antibodies against hepatitis C virus (HCV): a potential treatment to prevent HCV reinfection in liver transplant patients.

J Virol. 2006 Mar;80(6):2654-64. doi: 10.1128/JVI.80.6.2654-2664.2006.

Human monoclonal antibody to hepatitis C virus E1 glycoprotein that blocks virus attachment and viral infectivity.

J Virol. 2004 Jul;78(13):7257-63. doi: 10.1128/JVI.78.13.7257-7263.2004.

Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes.

J Virol. 2000 Nov;74(22):10407-16. doi: 10.1128/jvi.74.22.10407-10416.2000.

Neutralizing human monoclonal antibodies to conformational epitopes of human T-cell lymphotropic virus type 1 and 2 gp46.

J Virol. 1997 Aug;71(8):5828-40. doi: 10.1128/JVI.71.8.5828-5840.1997.

A source of glycosylated human T-cell lymphotropic virus type 1 envelope protein: expression of gp46 by the vaccinia virus/T7 polymerase system.

J Virol. 1996 Nov;70(11):7349-59. doi: 10.1128/JVI.70.11.7349-7359.1996.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验